| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |